Human bone marrow derived mesenchymal stem cells regulate Th17 cells of peripheral blood in vitro
10.3760/cma.j.issn.1009-9921.2013.07.008
- VernacularTitle:人骨髓来源的间充质干细胞体外对外周血Th17细胞的调节作用
- Author:
Simei REN
;
Hong LU
;
Ying YAN
;
Haifei WANG
;
Bo XIE
- Publication Type:Journal Article
- Keywords:
Mesenchymal stem cells;
Leukemia,myeloid,acute;
Interleukin-17;
Th17 cells
- From:
Journal of Leukemia & Lymphoma
2013;22(7):406-409
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the in vitro effects of human bone marrow derived mesenchymal stem cells (hBMSC) on Th17 cells of the human peripheral blood.Methods The density gradient centrifugation combined with lymphocyte separation medium was used to isolate hBMSC,which were then cultured.Cytokine IL-17 in the peripheral blood from a healthy person was measured by enzyme-linked immunosorbent assay (ELISA).Proportion of Th17 cells was evaluated by flow cytometry.Results The expression level of IL-17 in spent culture supernatant of the healthy person PBMC and AML hBMSC was (292.32±37.25) pg/ml,and was significantly higher than that of the healthy person PBMC and healthy hBMSC [(169.64±17.47) pg/ml,P ＜ 0.01].There was no significant difference between the expression level of IL-17 in spent culture supernatant of the healthy person PBMC and ALL hBMSC [(159.89±23.71) pg/ml] and the level of the healthy person PBMC and hBMSC.The percentages of Th17 cells of co-culture systems from hBMSC,ALL-hBMSC,and AML-hBMSC and PBMC were (10.13±2.19) ％,(13.77±4.04) ％ and (21.53±5.05) ％,respectively,with the result between AML patients and healthy people being statistically different (P ＜ 0.01).ALL patients and healthy people showed no difference (P ＞ 0.05).Conclusion AML-hBMSC promotes the CD~ T cells to generate Th17 cells,which suggests that the MSC from AML marrow may play a role in the regulation of immune suppression.
